...
首页> 外文期刊>Energy Business Journal >Data on Robotics - Nanotechnology - Biomimetics Described by Researchers at GlaxoSmithKline
【24h】

Data on Robotics - Nanotechnology - Biomimetics Described by Researchers at GlaxoSmithKline

机译:葛兰素史克(GlaxoSmithKline)研究人员描述的机器人技术数据-纳米技术-仿生生物

获取原文
获取原文并翻译 | 示例
           

摘要

2011 MAR 14 - (VerticalNews.com) -- Researchers detail in 'Estimating unboundrnvolume of distribution and tissue binding by in vitro HPLC-based human serum albumin andrnimmobilised artificial membrane-binding measurements,' new data in Robotics -rnNanotechnology - Biomimetics. "The in vivo unbound volume of distribution (V(du)) can bernused to estimate the free steady-state plasma concentration with a given dose of a drugrnadministered intravenously. We have demonstrated that the calibrated HPLC retention timesrnobtained on biomimetic stationary phases, such as immobilised human serum albumin andrnphosphatidyl-choline, can be used to estimate compounds' in vivo behaviour," researchers in the United Kingdom report.
机译:2011年3月14日-(VerticalNews.com)-研究人员详细介绍了“通过基于HPLC的人体血清白蛋白和固定化的人工膜结合测量方法估算分布和组织结合的无限量”,这是Robotics -nNanotechnology-Biomimetics中的新数据。 “可以使用体内未结合的分布体积(V(du))来估算给定剂量静脉内给药的药物的游离稳态血浆浓度。我们证明了在仿生固定相(例如:固定的人血清白蛋白和磷脂酰胆碱可用于评估化合物的体内行为。”

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号